Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 44, 2015 - Issue 5
205
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments

, , , , , , , , , , , , , & show all
Pages 482-496 | Received 29 Nov 2014, Accepted 01 Apr 2015, Published online: 24 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jingcai Lu, Jieshi Guo, Dandan Wang, Jinfei Yu, Tiejun Gu, Chunlai Jiang, Wei Kong & Yongge Wu. (2019) Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments. Human Vaccines & Immunotherapeutics 15:2, pages 371-380.
Read now
Dandan Wang, Jingcai Lu, Jinfei Yu, Hongjia Hou, Kees Leenhouts, Maarten L. Van Roosmalen, Tiejun Gu, Chunlai Jiang, Wei Kong & Yongge Wu. (2018) A Novel PspA Protein Vaccine Intranasal Delivered by Bacterium-Like Particles Provides Broad Protection Against Pneumococcal Pneumonia in Mice. Immunological Investigations 47:4, pages 403-415.
Read now
Kate Rittenhouse-Olson. (2015) Letter from the Editor. Immunological Investigations 44:8, pages 713-718.
Read now

Articles from other publishers (19)

Mona Shafaghi, Zohreh Bahadori, Seyed Mahmoud Barzi, Elnaz Afshari, Hamid Madanchi, Seyed Fazlollah Mousavi & Ali Akbar Shabani. (2023) A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Mona Shafaghi, Zohreh Bahadori, Hamid Madanchi, Mohammad Mehdi Ranjbar, Ali Akbar Shabani & Seyed Fazlollah Mousavi. (2023) Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains. BMC Bioinformatics 24:1.
Crossref
Qi Wei, Shixian Liu, Xu Huang, Hua Xin & Jianxun Ding. (2023) Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms. Biosafety and Health 5:1, pages 45-61.
Crossref
Pedro H. Silva, Yaneisi Vázquez, Camilo Campusano, Angello Retamal-Díaz, Margarita K. Lay, Christian A. Muñoz, Pablo A. González, Alexis M. Kalergis & Susan M. Bueno. (2022) Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Zohreh Bahadori, Mona Shafaghi, Hamid Madanchi, Mohammad Mehdi Ranjbar, Ali Akbar Shabani & Seyed Fazlollah Mousavi. (2022) In silico designing of a novel epitope-based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant. Journal of Translational Medicine 20:1.
Crossref
Shanshan Jin, Tongtong Wang, Yan Zhao, Xue Liu, Yichen Wang, Lingchuan Jiang & Qiusheng Zhang. (2022) The heat-labile toxin B subunit of E. coli fused with VP6 from GCRV (Grass carp reovirus) was expressed and folded into an active protein in rice calli. Protein Expression and Purification 197, pages 106099.
Crossref
Mengze Guo, Xiaonan Guo, Chenxing Zhang, Shidong Zhu, Yue Zhang, Tiejun Gu, Wei Kong & Yongge Wu. (2022) Novel Pneumococcal Protein-Polysaccharide Conjugate Vaccine Based on Biotin-Streptavidin. Infection and Immunity 90:1.
Crossref
Lazara Elena Santiesteban-Lores, Joaquín Cabrera-Crespo & Eneas Carvalho. (2021) Development of a pneumococcal conjugate vaccine based on chemical conjugation of polysaccharide serotype 6B to PspA. Microbial Pathogenesis 158, pages 105092.
Crossref
Kelly M. Martinovich, Tasmina Rahman, Camilla de Gier, Elke J. Seppanen, Tilda Orami, Caitlyn M. Granland, Jacinta Francis, Mition Yoannes, Karli J. Corscadden, Rebecca Ford, Peter Jacoby, Anita H. J. van den Biggelaar, Lauren O. Bakaletz, Allan W. Cripps, Deborah Lehmann, Peter C. Richmond, William S. Pomat, Lea-Ann S. Kirkham & Ruth B. Thornton. (2021) Differences in Pneumococcal and Haemophilus influenzae Natural Antibody Development in Papua New Guinean Children in the First Year of Life. Frontiers in Immunology 12.
Crossref
I. M. Gruber, O. M. Kukina, N. B Egorova, & O. V. Zhigunova. (2021) Different Technologies for Obtaining Pneumococcal Immunogens. Epidemiology and Vaccinal Prevention 20:1, pages 76-91.
Crossref
Xiaonan Guo, Qing Sun, Hualong Xi, Yue Zhang, Mengze Guo, Chenxing Zhang, Shidong Zhu, Tiejun Gu, Wei Kong & Yongge Wu. (2021) Expression, purification, and characterization of pneumococcal PsaA-PspA fusion protein. Protein Expression and Purification 178, pages 105782.
Crossref
Aline Pillot, Alain Defontaine, Amina Fateh, Annie Lambert, Maruthi Prasanna, Mathieu Fanuel, Muriel Pipelier, Noemi Csaba, Typhaine Violo, Emilie Camberlein & Cyrille Grandjean. (2019) Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation. Frontiers in Chemistry 7.
Crossref
Yue Zhang, Xiaonan Guo, Mengze Guo, Xiaorui Chen, Bo Li, Jinfei Yu, Tiejun Gu, Wei Kong & Yongge Wu. (2019) Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections. Immunologic Research 67:4-5, pages 398-407.
Crossref
Xiaorui Chen, Bo Li, Jinfei Yu, Yue Zhang, Zujian Mo, Tiejun Gu, Wei Kong, Yong Zhang & Yongge Wu. (2019) Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant. Medical Microbiology and Immunology 208:2, pages 215-226.
Crossref
Maruthi Prasanna, Daphnée Soulard, Emilie Camberlein, Nicolas Ruffier, Annie Lambert, François Trottein, Noemi Csaba & Cyrille Grandjean. (2019) Semisynthetic glycoconjugate based on dual role protein/PsaA as a pneumococcal vaccine. European Journal of Pharmaceutical Sciences 129, pages 31-41.
Crossref
Theano Lagousi, Paraskevi Basdeki, John Routsias & Vana Spoulou. (2019) Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens. Vaccines 7:1, pages 9.
Crossref
Bo Li, Xiaorui Chen, Jinfei Yu, Yue Zhang, Zujian Mo, Tiejun Gu, Wei Kong & Yongge Wu. (2018) Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice. Microbial Pathogenesis 123, pages 115-119.
Crossref
Jinfei Yu, Xiaorui Chen, Bo Li, Tiejun Gu, Xiangyu Meng, Wei Kong & Yongge Wu. (2018) A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains. Immunologic Research 66:4, pages 528-536.
Crossref
Jinfei Yu, Bo Li, Xiaorui Chen, Jingcai Lu, Dandan Wang, Tiejun Gu, Wei Kong & Yongge Wu. (2018) Comparison of Immunogenicity and Protection of Two Pneumococcal Protein Vaccines Based on PsaA and PspA. Infection and Immunity 86:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.